GC Biopharma Advances mRNA Vaccine, Innovative Brain Monitoring Technique, Daratumumab Boosts Myeloma Survival, Scientists Develop Lyme-Resistant Mice, and more... episode artwork

EPISODE · Sep 22, 2025 · 9 MIN

GC Biopharma Advances mRNA Vaccine, Innovative Brain Monitoring Technique, Daratumumab Boosts Myeloma Survival, Scientists Develop Lyme-Resistant Mice, and more...

from Science News Daily · host brief.news

GC Biopharma Advances mRNA Vaccine GC4006A with Domestic IND Application for Clinical Trials in KoreaRevolutionary Brain Monitoring Technique Uses Ultra-Thin Electrodes for Non-Invasive Access to Deep Brain RegionsDaratumumab Enhances Myeloma Treatment: Boosts Long-Term Survival, Revolutionizes Post-Transplant CareNantucket Scientists Use CRISPR to Create Lyme-Immune Mice, Raising Ecological ConcernsIIT-BHU and BHU Faculty Among Stanford's Top 2% Global Scientists for Research ExcellenceTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: Asia Research News

Episode metadata supplied by the publisher feed · Published Sep 22, 2025

Embed this episode

Ready to play

GC Biopharma Advances mRNA Vaccine, Innovative Brain Monitoring Technique, Daratumumab Boosts Myeloma Survival, Scientists Develop Lyme-Resistant Mice, and more...

0:00 9:03

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Science News Daily?

This episode is 9 minutes long.

When was this Science News Daily episode published?

This episode was published on September 22, 2025.

Can I download this Science News Daily episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!